Literature DB >> 18709374

[Fulminant process of an orbital Mucoracea infection].

C Jägle1, E Papageorgiou, S Preyer, H Löwenheim, U Schiefer, H Jägle.   

Abstract

Rhinoorbitocerebral mucormycosis is a rare invasive fungal infection that is fatal when untreated. We describe an immunosuppressed patient with chronic lymphatic leukaemia who developed a severe rhinoorbitocerebral mucormycosis after allogeneic bone marrow transplantation. Due to the potentially fulminant course and fatal outcome, radical excision of the necrotic area in combination with antifungal therapy is necessary in the presence of suspicious clinical signs of mucormycosis despite a lack of histopathologic confirmation.

Entities:  

Mesh:

Year:  2009        PMID: 18709374     DOI: 10.1007/s00347-008-1830-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  8 in total

1.  Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.

Authors:  R W Pelton; E A Peterson; B C Patel; K Davis
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2001-01       Impact factor: 1.746

2.  Mucormycosis; report of a case.

Authors:  J S HARRIS
Journal:  Pediatrics       Date:  1955-12       Impact factor: 7.124

Review 3.  [New aspects of infections caused by Aspergillus and Mucor and other filamentous fungi in immunosuppressed patients].

Authors:  E Bouza
Journal:  Rev Clin Esp       Date:  1995-10       Impact factor: 1.556

4.  Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.

Authors:  C Fairley; T J Sullivan; P Bartley; T Allworth; R Lewandowski
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

5.  [Potentially fatal orbital disorder].

Authors:  J von Eicken; S Preyer; H Wilhelm
Journal:  Klin Monbl Augenheilkd       Date:  2004-11       Impact factor: 0.700

Review 6.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 7.  Survival factors in rhino-orbital-cerebral mucormycosis.

Authors:  R A Yohai; J D Bullock; A A Aziz; R J Markert
Journal:  Surv Ophthalmol       Date:  1994 Jul-Aug       Impact factor: 6.048

Review 8.  Ocular and orbital phycomycosis.

Authors:  J N Schwartz; E H Donnelly; G K Klintworth
Journal:  Surv Ophthalmol       Date:  1977 Jul-Aug       Impact factor: 6.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.